GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (OTCPK:RDPTF) » Definitions » FCF Yield %

Radiopharm Theranostics (Radiopharm Theranostics) FCF Yield % : -147.20 (As of May. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Radiopharm Theranostics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Radiopharm Theranostics's Trailing 12-Month Free Cash Flow is $-16.35 Mil, and Market Cap is $10.06 Mil. Therefore, Radiopharm Theranostics's FCF Yield % for today is -147.20%.

The historical rank and industry rank for Radiopharm Theranostics's FCF Yield % or its related term are showing as below:

RDPTF' s FCF Yield % Range Over the Past 10 Years
Min: -6784.65   Med: 0   Max: 0
Current: -147.2


RDPTF's FCF Yield % is ranked worse than
90.02% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs RDPTF: -147.20

Radiopharm Theranostics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Radiopharm Theranostics FCF Yield % Historical Data

The historical data trend for Radiopharm Theranostics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics FCF Yield % Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
FCF Yield %
- -51.34

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % - - - -52.40 -47.12

Competitive Comparison of Radiopharm Theranostics's FCF Yield %

For the Biotechnology subindustry, Radiopharm Theranostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radiopharm Theranostics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's FCF Yield % falls into.



Radiopharm Theranostics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Radiopharm Theranostics's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-16.6 / 32.33385
=-51.34%

Radiopharm Theranostics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-7.88 * 2 / 33.44751
=-47.12%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Radiopharm Theranostics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics (Radiopharm Theranostics) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (Radiopharm Theranostics) Headlines

From GuruFocus

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 07-10-2022

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 06-10-2022

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 06-20-2022

RAD adds brain tumor technology to portfolio

By PRNewswire PRNewswire 06-30-2022

PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

By PRNewswire PRNewswire 10-19-2022